L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 23,178 shares at $17.86 ($415K) on 2016-11-25, disclosed to the SEC on 2016-11-25.
Open-market sale of $415k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.86 | 11,178 | $200K | 48.1% |
| 2 | $17.86 | 11,178 | $200K | 48.1% |
| 3 | $18.70 | 822 | $15K | 3.7% |
| Total | $17.89 avg | 23,178 | $415K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |